Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | FAAH | O00519 | 4/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6602946 | 0.91 | TSHR (0.44) | LMNATSHRFAAHCNR1CNR2 | |
| SCHEMBL229792 | 0.88 | TSHR (0.50) | LMNATSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL29467311 | 0.87 | LMNA (0.47) | LMNATSHRFAAHCNR1CNR2 | |
| SCHEMBL181911 | 0.87 | LMNA (0.47) | LMNATSHRFAAHCNR1CNR2 | |
| SCHEMBL11133563 | 0.87 | LMNA (0.42) | LMNATSHRFAAHCNR1CNR2 | |
| SCHEMBL28727541 | 0.86 | LMNA (0.48) | LMNATSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL28875912 | 0.86 | LMNA (0.48) | LMNATSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL18152012 | 0.86 | LMNA (0.48) | LMNATSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL1037280 | 0.85 | FAAH (0.56) | LMNATSHRFAAHCNR1CNR2 | |
| SCHEMBL28619359 | 0.85 | LMNA (0.41) | LMNATSHRFAAHCNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | claimed |
| US-20230350299-A1 | STEP SUBSTRATE COATING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230244141-A1 | PHOTOCURABLE COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-11681223-B2 | Photocurable composition and method for producing semiconductor device | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-20 | — | — | US | disclosed |
| US-11674051-B2 | Stepped substrate coating composition containing compound having curable functional group | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-13 | — | — | US | disclosed |
| US-11454889-B2 | Crosslinkable compound-containing photocurable stepped substrate-coating composition | NISSAN CHEMICAL CORPORATION (JP) | 2022-09-27 | — | — | US | disclosed |
| US-11385546-B2 | Multi-level substrate coating film-forming composition containing plasma-curable compound based on unsaturated bonds between carbon atoms | NISSAN CHEMICAL CORPORATION (JP) | 2022-07-12 | — | — | US | disclosed |
| US-11199777-B2 | Resist underlayer film-forming composition containing novolac polymer having secondary amino group | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-12-14 | — | — | US | disclosed |
| US-11155684-B2 | Photocrosslinkable group-containing composition for coating stepped substrate | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| US-20210024773-A1 | STEPPED SUBSTRATE COATING COMPOSITION CONTAINING COMPOUND HAVING CURABLE FUNCTIONAL GROUP | NISSAN CHEMICAL CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| US-20070205400-A1 | Varnish Containing Good Solvent And Poor Solvent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1773102-A1 | VARNISH CONTAINING GOOD SOLVENT AND POOR SOLVENT | Nissan Chemical Industries, Ltd. (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20030065183-A1 | Process for producing optically active tropinonemonocarboxylic acid ester derivative | NIHON MEDI-PHYSICS CO., LTD. | 2003-04-03 | — | — | US | disclosed |
| US-6486323-B1 | Process for producing optically active tropinonemonocarboxylic acid derivative | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-11-26 | — | — | US | disclosed |
| EP-1118674-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE TROPINONE MONOCARBOXYLIC ACID DERIVATIVE | Nihon Medi-Physics Co., Ltd. (JP) | 2001-07-25 | — | — | EP | disclosed |
| EP-0708105-B1 | 5-HT4 receptor agonists | NISSHIN FLOUR MILLING CO (JP) | 1998-12-23 | — | — | EP | disclosed |
| US-5684003-A | GASTROINTESTINAL DISORDERS OR ANTIULCER AGENTS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-11-04 | — | — | US | disclosed |
| EP-0708105-A1 | 5-HT4 receptor agonists | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | disclosed |
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065183-A1 | Process for producing optically active tropinonemonocarboxylic acid ester derivative | CES2, FTO, HAAO | LMNA 3458/4885TSHR 2020/4885FAAH 582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.